Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Why Mutual Funds & Institutional Investors Are Buying TBP

<< Previous

Bullboard Posts

Next >>

Comment by SamV21on Feb 05, 2022 5:06pm

101 Views

Post# 34401422

RE:RE:Why Mutual Funds & Institutional Investors Are Buying TBP

Guy Chamberland only holds 311,000 shares personally the balance of 4,815,436 Common Shares is held by 9315-4466 Quebec Inc. , a private company controlled by Dr. Chamberland.
That private company shows an income of 722,000.00 us a year , while shareholders sit on .10 a share, does Panag Pharma pay him ? they have income from Tetra product ,what about Intelgenx undisclosed amounts .Its all just a make work project on old science.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks